ID   RARG_MOUSE              Reviewed;         458 AA.
AC   P18911; P20787; Q3UG86; Q62149; Q91VK5; Q91YX2;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 3.
DT   07-APR-2021, entry version 205.
DE   RecName: Full=Retinoic acid receptor gamma;
DE            Short=RAR-gamma;
DE   AltName: Full=Nuclear receptor subfamily 1 group B member 3;
GN   Name=Rarg; Synonyms=Nr1b3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=2544807; DOI=10.1038/339714a0;
RA   Zelent A., Krust A., Petkovich M., Kastner P., Chambon P.;
RT   "Cloning of murine alpha and beta retinoic acid receptors and a novel
RT   receptor gamma predominantly expressed in skin.";
RL   Nature 339:714-717(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=2157970; DOI=10.1128/mcb.10.5.2335;
RA   Giguere V., Shago M., Zirngibl R., Tate P., Rossant J., Varmuza S.;
RT   "Identification of a novel isoform of the retinoic acid receptor gamma
RT   expressed in the mouse embryo.";
RL   Mol. Cell. Biol. 10:2335-2340(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=Czech II; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-74 (ISOFORMS 1; 2 AND 3).
RX   PubMed=2157210; DOI=10.1073/pnas.87.7.2700;
RA   Kastner P., Krust A., Mendelsohn C., Garnier J.-M., Zelent A., Leroy P.,
RA   Staub A., Chambon P.;
RT   "Murine isoforms of retinoic acid receptor gamma with specific patterns of
RT   expression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2700-2704(1990).
RN   [6]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=8388780; DOI=10.1016/0092-8674(93)90246-m;
RA   Lohnes D., Kastner P., Dierich A., Mark M., LeMeur M., Chambon P.;
RT   "Function of retinoic acid receptor gamma in the mouse.";
RL   Cell 73:643-658(1993).
RN   [7]
RP   IDENTIFICATION IN A COMPLEX WITH PUS1 AND SRA1, AND SUBCELLULAR LOCATION.
RX   PubMed=15327771; DOI=10.1016/j.molcel.2004.06.044;
RA   Zhao X., Patton J.R., Davis S.L., Florence B., Ames S.J., Spanjaard R.A.;
RT   "Regulation of nuclear receptor activity by a pseudouridine synthase
RT   through posttranscriptional modification of steroid receptor RNA
RT   activator.";
RL   Mol. Cell 15:549-558(2004).
RN   [8]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=19389355; DOI=10.1016/j.ydbio.2009.01.031;
RA   Williams J.A., Kondo N., Okabe T., Takeshita N., Pilchak D.M., Koyama E.,
RA   Ochiai T., Jensen D., Chu M.L., Kane M.A., Napoli J.L., Enomoto-Iwamoto M.,
RA   Ghyselinck N., Chambon P., Pacifici M., Iwamoto M.;
RT   "Retinoic acid receptors are required for skeletal growth, matrix
RT   homeostasis and growth plate function in postnatal mouse.";
RL   Dev. Biol. 328:315-327(2009).
RN   [9]
RP   DISRUPTION PHENOTYPE, POSSIBLE FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=20043900; DOI=10.1016/j.ydbio.2009.12.024;
RA   Pennimpede T., Cameron D.A., MacLean G.A., Petkovich M.;
RT   "Analysis of Cyp26b1/Rarg compound-null mice reveals two genetically
RT   separable effects of retinoic acid on limb outgrowth.";
RL   Dev. Biol. 339:179-186(2010).
RN   [10]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-34, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Receptor for retinoic acid. Retinoic acid receptors bind as
CC       heterodimers to their target response elements in response to their
CC       ligands, all-trans or 9-cis retinoic acid, and regulate gene expression
CC       in various biological processes. The RAR/RXR heterodimers bind to the
CC       retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3'
CC       sites known as DR1-DR5. In the absence of ligand, acts mainly as an
CC       activator of gene expression due to weak binding to corepressors (By
CC       similarity). Required for limb bud development. In concert with RARA or
CC       RARB, required for skeletal growth, matrix homeostasis and growth plate
CC       function. {ECO:0000250, ECO:0000269|PubMed:19389355,
CC       ECO:0000269|PubMed:8388780}.
CC   -!- SUBUNIT: Homodimer (By similarity). Heterodimer with a RXR molecule (By
CC       similarity). Binds DNA preferentially as a RAR/RXR heterodimer (By
CC       similarity). Forms a complex with PUS1 and the SRA1 RNA in the nucleus.
CC       {ECO:0000250, ECO:0000269|PubMed:15327771}.
CC   -!- INTERACTION:
CC       P18911; Q91XC0: Ajuba; NbExp=2; IntAct=EBI-8053650, EBI-1565930;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00407,
CC       ECO:0000269|PubMed:15327771}. Cytoplasm {ECO:0000250|UniProtKB:P13631}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=A;
CC         IsoId=P18911-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=P18911-2, P20787-1;
CC         Sequence=VSP_031082;
CC       Name=3;
CC         IsoId=P18911-3; Sequence=VSP_031081;
CC   -!- DEVELOPMENTAL STAGE: In 9.5-12.5 dpc embryos, expression throughout
CC       limb bud mesenchyme. This expression overlaps with that of CYP26B1.
CC       Also strongly expressed in the caudal and craniofacial regions.
CC       {ECO:0000269|PubMed:20043900}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain.
CC   -!- DISRUPTION PHENOTYPE: Rarg and Rarb double null mice exhibit growth
CC       retardation 3 weeks after birth. Defects are found in the growth plates
CC       with deficiency in cartilage. Growth retardation was noticable in limb
CC       sketal elements such as femurs. Early lethality and male sterility due
CC       to squamous metaplasia of the seminal vesicles and prostate are also
CC       observed. Isoform 2 mutants appear normal. The Rarg and Cyp26b1 double
CC       null mutation is able to partially rescue limb skeletal morphology
CC       without restoring normal expression of proximo-distal patterning genes.
CC       {ECO:0000269|PubMed:19389355, ECO:0000269|PubMed:20043900,
CC       ECO:0000269|PubMed:8388780}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X15848; CAA33845.1; -; mRNA.
DR   EMBL; M34475; AAA40036.1; -; mRNA.
DR   EMBL; M34476; AAA40035.1; -; mRNA.
DR   EMBL; AK148064; BAE28323.1; -; mRNA.
DR   EMBL; BC012923; AAH12923.1; -; mRNA.
DR   EMBL; BC013709; AAH13709.1; -; mRNA.
DR   EMBL; M32068; AAA40032.1; -; mRNA.
DR   EMBL; M32069; AAA40033.1; -; mRNA.
DR   EMBL; M32070; AAA40034.1; -; mRNA.
DR   CCDS; CCDS27875.1; -. [P18911-1]
DR   CCDS; CCDS37226.1; -. [P18911-2]
DR   PIR; B34714; B34714.
DR   PIR; S05052; A34714.
DR   RefSeq; NP_001036192.1; NM_001042727.2. [P18911-2]
DR   RefSeq; NP_035374.3; NM_011244.4. [P18911-1]
DR   RefSeq; XP_006520713.1; XM_006520650.1. [P18911-1]
DR   RefSeq; XP_011243827.1; XM_011245525.2. [P18911-1]
DR   SMR; P18911; -.
DR   BioGRID; 202595; 12.
DR   DIP; DIP-42822N; -.
DR   IntAct; P18911; 2.
DR   MINT; P18911; -.
DR   STRING; 10090.ENSMUSP00000048838; -.
DR   BindingDB; P18911; -.
DR   ChEMBL; CHEMBL4177; -.
DR   DrugCentral; P18911; -.
DR   GuidetoPHARMACOLOGY; 592; -.
DR   iPTMnet; P18911; -.
DR   PhosphoSitePlus; P18911; -.
DR   MaxQB; P18911; -.
DR   PaxDb; P18911; -.
DR   PeptideAtlas; P18911; -.
DR   PRIDE; P18911; -.
DR   ProteomicsDB; 255100; -. [P18911-1]
DR   ProteomicsDB; 255101; -. [P18911-2]
DR   ProteomicsDB; 255102; -. [P18911-3]
DR   Antibodypedia; 15142; 204 antibodies.
DR   Ensembl; ENSMUST00000043172; ENSMUSP00000048838; ENSMUSG00000001288. [P18911-1]
DR   Ensembl; ENSMUST00000063339; ENSMUSP00000067266; ENSMUSG00000001288. [P18911-2]
DR   GeneID; 19411; -.
DR   KEGG; mmu:19411; -.
DR   UCSC; uc007xvc.2; mouse. [P18911-2]
DR   UCSC; uc007xvd.2; mouse. [P18911-1]
DR   CTD; 5916; -.
DR   MGI; MGI:97858; Rarg.
DR   eggNOG; KOG3575; Eukaryota.
DR   GeneTree; ENSGT00940000156458; -.
DR   HOGENOM; CLU_007368_18_2_1; -.
DR   InParanoid; P18911; -.
DR   OMA; NKERLFP; -.
DR   OrthoDB; 1165737at2759; -.
DR   PhylomeDB; P18911; -.
DR   TreeFam; TF328382; -.
DR   Reactome; R-MMU-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-MMU-5362517; Signaling by Retinoic Acid.
DR   BioGRID-ORCS; 19411; 1 hit in 52 CRISPR screens.
DR   ChiTaRS; Rarg; mouse.
DR   PRO; PR:P18911; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; P18911; protein.
DR   Bgee; ENSMUSG00000001288; Expressed in lip and 348 other tissues.
DR   ExpressionAtlas; P18911; baseline and differential.
DR   Genevisible; P18911; MM.
DR   GO; GO:0000785; C:chromatin; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:BHF-UCL.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0004879; F:nuclear receptor activity; ISO:MGI.
DR   GO; GO:0046965; F:retinoid X receptor binding; IMP:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:MGI.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IMP:MGI.
DR   GO; GO:0060348; P:bone development; IMP:UniProtKB.
DR   GO; GO:0060349; P:bone morphogenesis; IMP:MGI.
DR   GO; GO:0043010; P:camera-type eye development; IGI:MGI.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEP:MGI.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IDA:MGI.
DR   GO; GO:0002063; P:chondrocyte development; IMP:UniProtKB.
DR   GO; GO:0031076; P:embryonic camera-type eye development; IGI:MGI.
DR   GO; GO:0048048; P:embryonic eye morphogenesis; IGI:MGI.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IGI:MGI.
DR   GO; GO:0060429; P:epithelium development; IMP:MGI.
DR   GO; GO:0060324; P:face development; IGI:MGI.
DR   GO; GO:0048732; P:gland development; IMP:MGI.
DR   GO; GO:0002068; P:glandular epithelial cell development; IGI:MGI.
DR   GO; GO:0003430; P:growth plate cartilage chondrocyte growth; IMP:UniProtKB.
DR   GO; GO:0003417; P:growth plate cartilage development; IGI:MGI.
DR   GO; GO:0070384; P:Harderian gland development; IMP:MGI.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0060173; P:limb development; IMP:UniProtKB.
DR   GO; GO:0035264; P:multicellular organism growth; IGI:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IGI:MGI.
DR   GO; GO:0061037; P:negative regulation of cartilage development; IMP:MGI.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; IMP:MGI.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IGI:MGI.
DR   GO; GO:0032331; P:negative regulation of chondrocyte differentiation; IMP:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0001843; P:neural tube closure; IGI:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IGI:MGI.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IGI:MGI.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:MGI.
DR   GO; GO:0043068; P:positive regulation of programmed cell death; IGI:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; IMP:MGI.
DR   GO; GO:0010468; P:regulation of gene expression; IGI:MGI.
DR   GO; GO:0031641; P:regulation of myelination; ISO:MGI.
DR   GO; GO:0045637; P:regulation of myeloid cell differentiation; IGI:MGI.
DR   GO; GO:0048608; P:reproductive structure development; IMP:MGI.
DR   GO; GO:0032526; P:response to retinoic acid; ISO:MGI.
DR   GO; GO:0060041; P:retina development in camera-type eye; IGI:MGI.
DR   GO; GO:0003406; P:retinal pigment epithelium development; IGI:MGI.
DR   GO; GO:0048384; P:retinoic acid receptor signaling pathway; IMP:MGI.
DR   GO; GO:0060534; P:trachea cartilage development; IMP:MGI.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR003078; Retinoic_acid_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01292; RETNOICACIDR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; DNA-binding; Isopeptide bond;
KW   Metal-binding; Methylation; Nucleus; Receptor; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..458
FT                   /note="Retinoic acid receptor gamma"
FT                   /id="PRO_0000053474"
FT   DOMAIN          185..419
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        90..155
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         90..110
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         126..150
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..89
FT                   /note="Modulating"
FT   REGION          156..184
FT                   /note="Hinge"
FT   MOD_RES         34
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   CROSSLNK        172
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P13631"
FT   CROSSLNK        401
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P13631"
FT   VAR_SEQ         1..62
FT                   /note="MATNKERLFAPGALGPGSGYPGAGFPFAFPGALRGSPPFEMLSPSFRGLGQP
FT                   DLPKEMASLS -> MHKGDNSGHQQVPRKRGHGMRVLLLSFCLSSHAAFHSA (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:2157210"
FT                   /id="VSP_031081"
FT   VAR_SEQ         1..61
FT                   /note="MATNKERLFAPGALGPGSGYPGAGFPFAFPGALRGSPPFEMLSPSFRGLGQP
FT                   DLPKEMASL -> MYDCMESFVPGPRRLYGAAGPGAGLLRRATGSSCFAGLESFAWAQP
FT                   ASLQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:2157210,
FT                   ECO:0000303|PubMed:2157970"
FT                   /id="VSP_031082"
FT   CONFLICT        63
FT                   /note="V -> E (in Ref. 3; BAE28323)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        78
FT                   /note="P -> A (in Ref. 3; BAE28323)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176
FT                   /note="S -> L (in Ref. 4; AAH13709)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        369..372
FT                   /note="RPSQ -> DPAK (in Ref. 2; AAA40035/AAA40036)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   458 AA;  50891 MW;  1D13D2F1482D7194 CRC64;
     MATNKERLFA PGALGPGSGY PGAGFPFAFP GALRGSPPFE MLSPSFRGLG QPDLPKEMAS
     LSVETQSTSS EEMVPSSPSP PPPPRVYKPC FVCNDKSSGY HYGVSSCEGC KGFFRRSIQK
     NMVYTCHRDK NCIINKVTRN RCQYCRLQKC FEVGMSKEAV RNDRNKKKKE VKEEGSPDSY
     ELSPQLEELI TKVSKAHQET FPSLCQLGKY TTNSSADHRV QLDLGLWDKF SELATKCIIK
     IVEFAKRLPG FTGLSIADQI TLLKAACLDI LMLRICTRYT PEQDTMTFSD GLTLNRTQMH
     NAGFGPLTDL VFAFAGQLLP LEMDDTETGL LSAICLICGD RMDLEEPEKV DKLQEPLLEA
     LRLYARRRRP SQPYMFPRML MKITDLRGIS TKGAERAITL KMEIPGPMPP LIREMLENPE
     MFEDDSSKPG PHPKASSEDE APGGQGKRGQ SPQPDQGP
//
